Published by
@ShahidNShah
@ShahidNShah
July 12 to July 13, 2023
The Westin Boston Seaport District, 425 Summer Street, Boston, Massachusetts, 02210, United States
Over the last 12 months, we have seen many combination therapies enter Phase I and II trials with both successes and challenges, particularly in solid tumors. The FDA Modernization Act 2.0 passing has also steered biopharma away from animal models, empowering the preclinical and translational tumor models' space to continue innovating and decrease the translational gap into the clinic.
At the 11th Annual Tumor Models Boston Summit, you will gain practical insights into the latest updates through 25+ case studies across 2 dedicated tracks. Join us to learn from and meet pioneers in preclinical and translational targeted, combination oncology to advance your candidates to patients with optimized translatability, efficiency, and cost-effectiveness!
Continue reading at tumor-models.com
July 13 to July 14, 2023
Abu Dhabi, United Arab Emirates
Connecting innovation decision makers to authoritative information, institutions, people and insights.
Medigy accurately delivers healthcare and technology information, news and insight from around the world.
Medigy surfaces the world's best crowdsourced health tech offerings with social interactions and peer reviews.
© 2024 Netspective Foundation, Inc. All Rights Reserved.
Built on Dec 20, 2024 at 12:59pm